DOI: 10.2337/diacare.29.04.06.dc05-1984 © 2006 by the American Diabetes Association
Uncoupling Protein 2 Promoter Polymorphism 866G/A Affects Peripheral Nerve Dysfunction in Japanese Type 2 Diabetic PatientsFrom The First Department of Medicine, Wakayama Medical University, Kimiidera, Wakayama, Japan Address correspondence and reprint requests to Hideyuki Sasaki, The First Department of Medicine, Wakayama Medical University, Kimiidera 811-1, Wakayama 641-8509, Japan. E-mail: sasaki-h{at}wakayama-med.ac.jp OBJECTIVETo determine genetic predispositions for diabetic polyneuropathy, we investigated the relationship between the 866G/A polymorphism of uncoupling protein (UCP) 2 and neurological manifestations in 197 type 2 diabetic patients. RESEARCH DESIGN AND METHODSWe first examined whether UCP2 mRNA had been expressed in the dorsal root ganglion (DRG) in four Long-Evans Tokushima Otsuka rats using RT-PCR and electrophoresis. Genotyping of UCP2 promoter polymorphism 866G/A was then performed in 197 unrelated Japanese type 2 diabetic patients, who were subjected to nerve conduction, quantitative vibratory perception, head-up tilt, and heart rate variability tests, by PCR restriction fragmentlength polymorphism. The relationships between UCP2 genotype and various nerve functions were analyzed by uni- and multivariable analysis. RESULTSExpression of UCP2 mRNA was confirmed in rat DRG. Multiple regression analysis clarified the hypothesis that the G/A + A/A genotype was significantly related to decreased motor nerve conduction velocity and impaired blood pressure maintenance on the head-up tilt test. Multiple logistic regression analysis revealed that the G/A + A/A genotypes are a significant risk factor for sensory nerve conduction slowing and orthostatic hypotension. CONCLUSIONSUCP2 promoter gene polymorphism 866 G/A was significantly associated with nerve conduction slowing and vasomotor sympathetic functions. These findings suggest that the higher UCP2 activity related to the A allele has an energy-depleting effect on peripheral nerve function in type 2 diabetic patients.
Abbreviations:
|
|
|
|||||||||||||||||||||||||||